Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
Top Cited Papers
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 118 (2) , 264-273
- https://doi.org/10.1016/s0016-5085(00)70208-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Oral contraceptive use and smoking are risk factors for relapse in Crohn's diseaseGastroenterology, 1998
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupGastroenterology, 1997
- Prognostic factors for postoperative recurrence of Crohn's diseaseDiseases of the Colon & Rectum, 1996
- Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseGastroenterology, 1995
- The prevention of Crohn's disease after surgery: Metronidazole is a small but continuous medical advancementGastroenterology, 1995
- Delivery and fate of oral mesalamine microgranules within the human small intestineGastroenterology, 1995
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Smoking and sugar intake are separate but interactive risk factors in Crohn's disease.Gut, 1988
- Recurrence and Reoperation for Crohn's DiseaseNew England Journal of Medicine, 1981